| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 08/09/2005 | CA2231700C Prodrugs of aspartyl protease inhibitors |
| 08/09/2005 | CA2195262C Phosphonate nucleotide compounds |
| 08/04/2005 | WO2005070990A1 An epoxy resin curing agent containing elemental phosphorus and the method for preparing the same |
| 08/04/2005 | WO2005070952A1 Lipid- derivatized bisphosphonic acid |
| 08/04/2005 | WO2005070901A2 Pyrimidyl phosphonate antiviral compounds and methods of use |
| 08/04/2005 | WO2005070875A1 Process for production of amines |
| 08/04/2005 | WO2005037206A3 Anti-cancer compounds and methods of use thereof |
| 08/04/2005 | WO2005019230A3 Process for the preparation of n-phosphono-methylglycine and derivatives thereof |
| 08/04/2005 | WO2004030750A8 Antisense modulation of farnesoid x receptor expression |
| 08/04/2005 | US20050171383 Organic borate compounds and the nonaqueous electrolytes and lithium secondary batteries using the compounds |
| 08/04/2005 | US20050171377 Sulfonating an arylphosphine with oleum, diluting with water, extracting with a water-insoluble amine in a water-insoluble organic solvent, reacting the water-immiscible organic phase with an inorganic base in water, adjusting to a pH of 3, using an inert gas stream to liberate sulfur dioxide |
| 08/04/2005 | US20050171376 Polyaminomethylenephos phonate derivatives |
| 08/04/2005 | US20050171367 Method for manufacturing a combined fatty acid / lecithin ruminally protected feed supplement. |
| 08/04/2005 | US20050171184 Resolution with acid; salt formation, cyclization |
| 08/04/2005 | US20050171082 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| 08/04/2005 | US20050171065 NAALADas, N-Acetylated-Alpha-Linked-Acidic-Dipeptidase inhibitors; 5-phosphonomethyl-1,3-benzenedicarboxylic Acid; glutamate abnormalities, anticancer, antidiabetic agent, angiogenesis inhibitor, neuropathy, pain, compulsive disorders, prostate diseases, glaucoma |
| 08/04/2005 | US20050171060 Anticancer agents and drug delivery agents with nucleotides |
| 08/04/2005 | US20050171044 Oligonucleotide compound and method for treating nidovirus infections |
| 08/04/2005 | US20050170529 Apparatus which utilizes fluoresence from europium chelates as detection tool in cell imaging, flow cytometry and immunohistochemistry assays |
| 08/04/2005 | US20050170508 For transfecting nucleic acids in vivo or ex vivo; vesicle forming lipid and hydrophilic polymer; gene therapy |
| 08/04/2005 | US20050170363 For conjugation with biomolecules, drugs, and toxins |
| 08/04/2005 | US20050170063 Extraction of phospholipid from lecithin with supercritical fluid; removal of residual alcohol; separation of solids as powder; mixer, extraction vessel, continuous process |
| 08/04/2005 | DE102004002834A1 Production of phosphoric acid triester involves reacting an alcohol with phosphorus oxychloride in a reactor fitted with a means of increasing the surface area of the reaction mixture |
| 08/04/2005 | DE102004002053A1 Verfahren zur Herstellung von Phosphatidylserin und dessen Reinigung durch Extraktion Process for the preparation of phosphatidylserine by extraction and purification thereof |
| 08/04/2005 | CA2552584A1 Pyrimidyl phosphonate antiviral compounds and methods of use |
| 08/03/2005 | EP1559718A1 Combretastatin A-4 phosphate prodrug salts with nitrogen-containing compounds |
| 08/03/2005 | EP1558587A1 Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents |
| 08/03/2005 | EP1558562A1 Cationic cardiolipin analogs and use thereof |
| 08/03/2005 | EP1558384A1 Mixtures of chiral monophosphorus compounds used as ligand systems for asymmetric transition metal catalysis |
| 08/03/2005 | EP1429750A4 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 08/03/2005 | EP1284737B1 Water soluble prodrugs of azole compounds |
| 08/03/2005 | EP1163196B1 Method for producing alcohol surfactants and alcohol ether surfactants, the products obtained and their use |
| 08/03/2005 | CN1649988A Method for extracting lipid mixture containing phospholipids comprising polyunsaturated fatty acids from viscera of fish |
| 08/03/2005 | CN1649885A Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
| 08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/03/2005 | CN1649830A Substituted aryl ketones |
| 08/03/2005 | CN1649559A Photosensitive adhesive composition |
| 08/03/2005 | CN1648131A Process for treating glyphosate mother liquid |
| 08/03/2005 | CN1213090C One-pack moisture-curable epoxy resin composition |
| 08/02/2005 | US6924396 α-haloenamine reagents |
| 08/02/2005 | US6924389 Method for producing diphosphines and the use thereof |
| 08/02/2005 | US6924345 Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions |
| 08/02/2005 | US6924307 Metalloproteinase inhibitor; antiarthritic agents, osteoporosis; cardiovascular disorders; antitumor agents; autoimmune diseases |
| 08/02/2005 | US6924292 Nitrogen compounds such as 2-(methylsulfinyl) N [3-(3,4,8,9-tetrahydro-6-methoxy-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)phenyl]acetamide, used as phosphodiesterase inhibitors; antidiabetics; antiinflammatory agents |
| 08/02/2005 | CA2304821C Osteoblast-specific mitogens and drugs containing such compounds |
| 08/02/2005 | CA2124599C Process of inhibition oxalate scale formation |
| 07/28/2005 | WO2005068644A1 Method for production of phosphatidylserine and purification thereof by extraction |
| 07/28/2005 | WO2005068480A1 Sphingomyelin, intermediates thereof and methods for preparation of same |
| 07/28/2005 | WO2005068479A1 A method for generating secondary phosphines |
| 07/28/2005 | WO2005068420A1 Urea and thiourea compounds and compositions for cholesterol management and related uses |
| 07/28/2005 | WO2005068418A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 07/28/2005 | WO2005068412A1 Ketone compounds and compositions for cholesterol management and related uses |
| 07/28/2005 | WO2005048715A3 Organophosphoric compounds and use thereof |
| 07/28/2005 | WO2005044831A3 A process for preparation of bisphosphonic acid compounds |
| 07/28/2005 | WO2002096905A8 Thiazole compounds useful as inhibitors of protein kinases |
| 07/28/2005 | US20050165248 cake of salt of organic or oxygen-containing inorganic acid or alkoxide reactant on filter element flowed through by solution of acid halide or alkyl halide reactant; insoluble halide salt formed remains on on the filter element |
| 07/28/2005 | US20050165245 Transferring drugs; antitumor agents, anticancer agents |
| 07/28/2005 | US20050164989 Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative |
| 07/28/2005 | US20050164988 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 07/28/2005 | US20050164963 Components for producing amphoteric liposomes |
| 07/28/2005 | US20050164916 Glycopeptide phosphonate derivatives |
| 07/28/2005 | US20050164874 Bisphosphine process for producing the same and use thereof |
| 07/28/2005 | US20050164872 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
| 07/28/2005 | US20050164296 reaction product of a meso-porous organofunctional silica and a ligand; organofunctional silica is prepared from an alkyl silicate and at least one organofunctional silane which contains a group reactive with ligand functional group |
| 07/28/2005 | US20050164268 Oncology diagnosis; gene overexpression/underexpression; tumor suppressor genes |
| 07/28/2005 | US20050164225 Bis-diazo,triaryl and aryldiazo-N-arylphenazonium moieties; labels for polynucleotides, nucleosides, nucleotides, and polypeptides; fluorescence resonance energy transfer |
| 07/28/2005 | US20050164093 Lithiated organic phosphazene derivative; combustion suppression; high energy density, long service life microelectronic power sources; synthesis |
| 07/28/2005 | US20050164092 Organic solution of polyphosphonic acid tetravalent metal salt; easy insertion of particles into pores; high catalytic activity; heat resistance |
| 07/28/2005 | DE10360772A1 Verfahren zur Herstellung von Organoacylphosphiten A process for preparing Organoacylphosphiten |
| 07/28/2005 | DE10360771A1 Verfahren zur Herstellung von dreiwertigen Organophosphor-Verbindungen Process for preparing trivalent organophosphorus compounds |
| 07/28/2005 | DE10359815A1 Verfahren zur Herstellung von Dialkylphosphinsäure-Salzen Process for the preparation of dialkylphosphinic salts |
| 07/28/2005 | DE10359814A1 Dialkylphosphinsäure-Salze Dialkylphosphinate salts |
| 07/28/2005 | CA2553608A1 Process for the production of asymmetric transformation catalysts |
| 07/28/2005 | CA2553607A1 Metallocene-based chiral phosphine or arsine ligands |
| 07/28/2005 | CA2552797A1 Sphingomyelin, intermediates thereof and methods for preparation of same |
| 07/27/2005 | EP1557424A1 Bi-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 07/27/2005 | EP1557423A1 Transition metal complexes and polymerization catalysts |
| 07/27/2005 | EP1557416A1 Oxazolidinone-quinolone hybrid antibiotics |
| 07/27/2005 | EP1557410A2 Bacterial gyrase inhibitors and uses thereof |
| 07/27/2005 | EP1556437A1 Antistatic agents and polymer compositions derived therefrom |
| 07/27/2005 | EP1556398A1 Novel cytarabine monophosphate prodrugs |
| 07/27/2005 | EP1556393A2 Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs |
| 07/27/2005 | EP1556392A1 Cardiolipin molecules and method of synthesis |
| 07/27/2005 | EP1556391A2 Lipid-analog phosphoric acid triester |
| 07/27/2005 | EP1556390A2 Functionalized ionic liquids, and methods of use thereof |
| 07/27/2005 | EP1556325A1 Anthraquinone quencher dyes, their methods of preparation and use |
| 07/27/2005 | EP1556323A2 Metal chelates and methods of using them for time-resolved fluorescence |
| 07/27/2005 | EP1556059A1 Thrombopoietin mimetics |
| 07/27/2005 | EP1556041A1 A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid |
| 07/27/2005 | EP1556032A1 Agent for preventing or treating neuropathy |
| 07/27/2005 | EP1095047B1 Preparation of thiophosphonoformate esters |
| 07/27/2005 | EP0942914B1 Synthesis of ruthenium or osmium metathesis catalysts |
| 07/27/2005 | CN1646547A Bisphosphines as bidentate ligands |
| 07/27/2005 | CN1646546A Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof |
| 07/27/2005 | CN1646545A Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates |
| 07/27/2005 | CN1646544A Process for manufacturing purified phosphorodiamidite |
| 07/27/2005 | CN1646540A Functionalized ionic liquids, and methods of use thereof |
| 07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
| 07/27/2005 | CN1646460A 2-(2, 6-dichlorophenyl)-diarylimidazoles |
| 07/27/2005 | CN1646459A Method for producing ethers, esters or acid anhydrides |